Physician

Panayotis Ledakis, MD

According to 2025 Medicare claims, Panayotis Ledakis, MD (NPI: 1649385634) practices medical oncology in the Baltimore-Columbia-Towson, MD market, with the plurality of this provider's patient population coming from Baltimore, MD. This provider's primary affiliated billing organization is LUTHERVILLE HEMATOLOGY AND ONCOLOGY SERVICES (NPI: 1538454228; TIN: 27-4697590) and primary practice location at 21236-4088.

Ledakis' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,099 traditional Medicare patients, billed 294,119 HCPCS/CPT codes, and received $3,773,408 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 660 prescription claims across 256 beneficiaries totaling $820,843 in drug costs, led by Zejula (Niraparib Tosylate). DME data shows 12 claims. Open Payments data shows 38 records totaling $43,512. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $209,335 to $3,773,408. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $447,637 and ending at $820,843. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $2,542 to $70.